Article Text

SAT0113 Obesity and metabolic syndrome influence on n-terminal pro-brain natriuretic peptide levels in rheumatoid arthritis patients
  1. L Kondratyeva,
  2. T Popkova,
  3. I Kirillova,
  4. D Novikova,
  5. A Novikov,
  6. E Alexandrova,
  7. E Nasonov
  1. V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation


Background N-terminal pro-brain natriuretic peptide (NT-proBNP) is a recognized myocardial injure marker, a known predictor of heart failure and cardiovascular death. Rheumatoid arthritis (RA) patients (pts) were shown to have higher than in general population NT-proBNP concentrations, positively correlating with IL-6 levels. Adipose tissue is considered be one of the sources of this pro-inflammatory cytokine. But on the other hand, metabolic syndrome (MS) and obesity, which also occur in RA pts, are usually associated with lower NT-proBNP levels in general population.

Objectives To find out whether overweight/obesity or MS may modify NT-proBNP levels in RA pts.

Methods A total of 68 early RA pts (72% females, 28% males) was enrolled in the study. Mean disease duration was 6 [4;8] months, and RA activity using DAS28 calculator was 5,6 [5,1;6,4] scores. The majority of pts had positive RF (87%) and ACPA (88%). All pts were glucocorticoids and disease-modifying antirheumatic drugs - naïve prior to inclusion. The overweight/obesity was determined by WHO criteria in patients with body mass index (BMI) ≥25 kg/m2. National Cholesterol Education Program/Adult Treatment Panel III criteria were used to confirm MS. Serum levels of NT-proBNP (pg/mL) were measured using electrochemiluminescence test Elecsys proBNP II (Roche Diagnostics, Switzerland). NT-proBNP levels >125,0 pg/mL were considered as elevated.

Results Overweight and obesity were established in 54,4% RA pts. Overweight/obese RA pts were older than pts with normal BMI (57 [53;61] years vs 48 [34;61] years, p=0,02), had higher DAS28 scores (5,85 [5,20;6,57] vs 5,28 [4,76;5,69], p<0,01), higher CRP (38,8 [14,3; 47,9] mg/L vs 12,8 [2,2;28,8] mg/L, p<0,01). Elevated NT-proBNP concentrations were found in 62,2% overweight/obese pts vs 29,0% pts with normal weight (p<0,01), median NT-proBNP concentrations were 153,4 [87,3;236,9] pg/mL vs 75,2 [40,2;147,4] pg/mL, respectively (p=0,02). MS was established in 62,2% pts with BMI ≥25kg/m2 and in 25,8% pts with BMI<25kg/m2 (p<0,01). Median NT-proBNP concentrations did not vary significantly in pts with and without MS, whether they were overweight/obese (p=0,75), or had normal BMI (p=0,27). Although higher rates of elevated NT-proBNP concentrations were documented in pts with MS (61,3% vs 35,1%, p=0,03). NT-proBNP levels positively correlated with waist circumference (r=0,33, p<0,01), ESR (r=0,25, p=0,04), and CRP (r=0,3, p=0,01).

Conclusions Overweight and obesity in RA pts were associated with increased NT-proBNP levels. Abdominal obesity was identified as the only MS component, influencing NT-proBNP levels, presumably via up-regulation of the inflammatory process.

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.